Related Articles
Reports from the field
Covid-19 has delayed the diagnosis and treatment of cancer in hospitals around the world. Lockdowns and travel restrictions have prevented the shipping, installation, clinical use and servicing of life-saving radiation therapy systems. Despite this, the West African country Togo has been remarkable in launching the county’s first linac. According to the WHO, approximately 70 percent of…
The intense interest in the potential of MR-guided radiation therapy spurred researchers to cite – in great numbers in Physics in Medicine & Biology (PMB) – a paper describing the 2017 first-in-human proof-of-concept study involving the prototype of Elekta Unity, the world’s first high-field (1.5T) MR-Linac. The 217 citations of the paper: “First patients treated…
When Serpil received her cancer diagnosis at 38, her thoughts immediately turned to her young children. Would her family be able to continue exploring cities, going on picnics or visiting her relatives in Turkey or her husband’s in Greece? And how would Covid-19 affect her access to cancer care? Serpil’s son had just stopped nursing…
It was already the most advanced magnetic resonance radiation therapy (MR/RT) system in the world when launched in 2018, nevertheless, Elekta’s MR-Linac, Elekta Unity, continues to evolve, and further sets us apart from our competitors. Motion related image artifacts are a common challenge with free-breathing MRI. The latest product release on Elekta Unity enables 3D…
“I was initially treated with chemotherapy, the most common treatment for Hodgkin lymphoma. Unfortunately, the cancer did not respond well so my doctor convinced me that a bone marrow transplant would be our best bet. But first we needed to use radiotherapy to reduce the lymph nodes as much as possible.” Thiago was treated in…
Scientists at the University of Toronto and Sunnybrook Health Sciences Centre reviewed their center’s first clinical use of the Elekta Unity MR-Linac. Chia-Lin (Eric) Tseng, MD, and Angus Lau, PhD, explained how they harnessed functional imaging MRI sequences, including diffusion-weighted imaging (DWI) to evaluate patients with CNS tumors, the majority being glioblastoma multiforme (GBM). The…
Clinicians at Niguarda Hospital’s (Milan, Italy) Gamma Knife unit recently published their experiences and insights on how they managed to keep their Gamma Knife® radiosurgery services up and running during the Covid-19 pandemic. Like countless Gamma Knife services worldwide, the crisis has required Niguarda Hospital staff to be extremely diligent to safeguard staff and patient…
Sara Morel, AAS, BS, CTR, Lead Cancer Registrar for MidMichigan Health (Midland, MI) was selected as Elekta’s 2020 Registrar of the Year, an honor that the company bestows on certified tumor registrars (CTR) who have made critical contributions to the success of their registry and profession. We recently spoke with Sara about her career path,…
As a leading innovator of precision radiation therapy solutions, Elekta is committed to ensuring that every patient has access to the best cancer care possible.
The products and product clinical indications for use described within FOCUS may not have clearance or registration in certain countries. Please consult Elekta in your country for questions concerning a product or clinical use subject. This site may contain information provided by third party sources to Elekta that does not necessarily represent the views of Elekta. Individuals interviewed provided information based on their personal experience and were not compensated for their participation. Accordingly, third party information contained in this site is provided "as is" with no guarantees of completeness, accuracy, usefulness, or timeliness.
© 2022 Elekta | FOCUS Magazine. | Privacy Policy | Cookies
